New Drug: Pacritinib for Myelofibrosis
|New Drug: Pacritinib for Myelofibrosis|
JAMA Oncol. 2018;4(5):652-659
Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis
Reviewed by Hasan Cagri Yildirim
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.